Home
Search
Search Results
Previously Searched
3122 results found
Expand All
Apply All
3122 results found

The power of science
Good Day BIO Newsletter  •  June 5, 2020
It’s World Environment Day, and we’re celebrating the power of science—how it can help clean up the planet, improve the economy, and get us through the pandemic. Here are around 850 words, 4 minutes, 15 seconds.
Read More

BIO’s Dr. McMurry-Heath Says Racism a “Chronic Disease” Plaguing Society
Press Release  •  June 4, 2020
Will lead discussion on race and equity with industry leaders Drs. Tony Coles, Ted Love, and Jeremy Levin next week In the wake of tragic deaths and civil unrest, BIO’s President and CEO Dr. Michelle McMurry-Heath announced she will lead a panel discussion next week at BIO Digital with industry leaders on the state of race and equity within the biotechnology industry.  Following the announcement, Dr. McMurry-Heath shared her thoughts on events that have taken place in recent days: “To say our country is at a crossroads would be an understatement. For the past few months, the world has been confronted by an unprecedented challenge in COVID-19, the likes of which we have not experienced in quite some time. Our BIO member companies have rallied to heed the call, working around the clock in the hopes of not only developing near-term solutions, but also long-term cures. And while this represents a more recent challenge, a more chronic disease has continued to plague the United States and many nations around the world for quite some time – racism. “It’s a word most of us are uncomfortable uttering in polite company, but one that we no less must get comfortable addressing. The senseless killings of George Floyd in Minnesota, Breonna Taylor in Kentucky and Ahmaud Arbery in Georgia have all forced the nation to confront an ugly truth, and that is, despite the tremendous progress we’ve made, we still have a long way to go.  “The peaceful protests taking place today are an important reminder that, only when the voices of Black Americans are heard and their experiences fully understood, will we begin the important process of healing that our nation so desperately needs in this moment. For our part, BIO stands with these peaceful protestors and hope that these concerns are not only amplified in the streets, but in the boardrooms and the halls of political power across our country that serve as important agents for change.  “When I decided to pursue…
Read More

Racism is a “chronic disease” plaguing society, says BIO’s Dr. McMurry-Heath
Good Day BIO Newsletter  •  June 4, 2020
We have an important announcement from BIO President and CEO Dr. Michelle McMurry-Heath about a new, must-attend BIO Digital session on race and the biotech industry. Here are about 500 words, 2 and a half minutes.
Read More

Pfizer’s investing $500 million in biotech breakthroughs
Good Day BIO Newsletter  •  June 3, 2020
Innovation. We know, we use this buzzword every single day around here—but it really is what’s driving the next generation of cures, what could prevent the next zoonotic disease pandemic, and what will get us out of this crisis. Today, we’re taking a look at how Pfizer’s investing in it, how regulatory policy could support it, and how one vaccine pioneer is using it to develop a few promising COVID-19 candidates. Here are around 777 words, just under 4 minutes.
Read More

BIO and CSBA Letter to Congress to Support One Health and Advance Animal Biotech
Agriculture & Environment, Food & Farm Innovation, Council for State Biotechnology Associations (CSBA)  •  Letters, Testimony & Comments  •  June 2, 2020
The Biotechnology Innovation Organization (BIO), along with the 27 members of the Council of State Bioscience Associations (CSBA), urge Congress to support the Advancing Emergency Preparedness Through One Health Act and advance legislation directing the U.S. Food and Drug Administration (FDA) and the U.S. Department of Agriculture (USDA) to develop a Memorandum of Understanding (MOU) to streamline the regulatory oversight of animal biotechnology. Elevating and prioritizing the relationship of living things through One Health strategies and modernizing America’s animal biotechnology regulatory approach are two policies Congress must address in any future COVID-19 legislation. Doing so will ensure we are ready for the next potential animal to human disease outbreak.
Read More

Business & Scientific Resources
Policy
Stopping Outbreaks Through One Health: Making Tomorrow's Breakthroughs Possible

Ag & Environment Response Efforts
Policy

2 antibody updates
Good Day BIO Newsletter  •  June 2, 2020
Today, we have updates from two members developing COVID-19 antibody therapeutics: SAB Biotherapeutics’ antibodies look incredibly potent in preclinical study, while Eli Lilly has launched a clinical trial for its antibody treatment. We have the details, plus news from the Senate, in around 930 words, or 4 minutes, 40 seconds.
Read More

A new chapter
Good Day BIO Newsletter  •  June 1, 2020
America is grappling with challenges that feel insurmountable: more than 100,000 dead due to the pandemic, record unemployment, the murder of George Floyd, and unrest in cities across the country, a reckoning with decades of injustice. Amid the turmoil, BIO is beginning a new chapter, today—with the kind of leadership our industry needs to help the country defeat the coronavirus and move forward. The vaccines and treatments we develop will not only save lives and allow us to return to work, school, and “normal” life. These cures will also allow us to come back together, speak face to face, hold hands and hug, and heal—and hopefully, return to a new, better normal. Today, we welcome Dr. Michelle McMurry-Heath on her first day as BIO’s President and CEO, bringing global leadership and a commitment to patients and to innovation across the biotech sector, from health care to industrial biotech to food and agriculture, which will drive our industry forward at this critical moment in history. Here are around 620 words, 3 minutes.
Read More

Map Test Page